Page last updated: 2024-11-05

tinidazole and Acute Lymphoid Leukemia

tinidazole has been researched along with Acute Lymphoid Leukemia in 1 studies

Tinidazole: A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.
tinidazole : 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.

Research Excerpts

ExcerptRelevanceReference
"Tinidazole was indicated, 2 g/day for 5 days in the first week of CT started."1.51Tinidazole efficacy for amebic colitis therapeutic prophylaxis in patients with de novo acute leukemia receiving intensive chemotherapy. ( Alvarado-Ibarra, M; Álvarez-Vera, JL; Arana-Luna, LL; Espitia-Ríos, ME; Mena-Zepeda, V; Ortiz-Zepeda, M; Peña-Celaya, JA; Zúñiga, JMP, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arana-Luna, LL1
Álvarez-Vera, JL1
Peña-Celaya, JA1
Mena-Zepeda, V1
Ortiz-Zepeda, M1
Espitia-Ríos, ME1
Zúñiga, JMP1
Alvarado-Ibarra, M1

Other Studies

1 other study available for tinidazole and Acute Lymphoid Leukemia

ArticleYear
Tinidazole efficacy for amebic colitis therapeutic prophylaxis in patients with de novo acute leukemia receiving intensive chemotherapy.
    Gaceta medica de Mexico, 2019, Volume: 155, Issue:Suppl 1

    Topics: Adolescent; Adult; Aged; Amebicides; Antineoplastic Combined Chemotherapy Protocols; Dysentery, Ameb

2019